ArticleESC heart failure2025

Real-world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure.

Ankeet S Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.